Stryker

YTD

ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.

CEO

Kevin A. Lobo

CEOKevin A. Lobo

Employees

56,000

Employees56,000

Headquarters

Portage, Michigan

HeadquartersPortage, Michigan

Founded

1941

Founded1941

Employees

56,000

Employees56,000

SYK Key Statistics

Market cap

119.83B

Market cap119.83B

Price-Earnings ratio

36.03

Price-Earnings ratio36.03

Dividend yield

1.12%

Dividend yield1.12%

Average volume

2.65M

Average volume2.65M

High today

$315.99

High today$315.99

Low today

$308.88

Low today$308.88

Open price

$313.20

Open price$313.20

Volume

191.92K

Volume191.92K

52 Week high

$404.87

52 Week high$404.87

52 Week low

$281.00

52 Week low$281.00

Stock Snapshot

With a market cap of 119.83B, Stryker(SYK) trades at $312.58. The stock has a price-to-earnings ratio of 36.03 and currently yields dividends of 1.12%.

On 2026-07-15, Stryker(SYK) stock moved within a range of $308.88 to $315.99. With shares now at $312.58, the stock is trading +1.2% above its intraday low and -1.1% below the session's peak.

Trading volume for Stryker(SYK) stock has reached 191.92K, versus its average volume of 2.65M.

Over the past 52 weeks, Stryker(SYK) stock has traded between a high of $404.87 and a low of $281.00.

SYK News

Simply Wall St 12h

Can Stryker Turn Nerve Repair Biomaterials Into a Core Neurotechnology Growth Engine?

Recent coverage of the nerve repair biomaterials sector highlighted rapid growth driven by regenerative medicine advances, minimally invasive techniques, and sm...

TipRanks 2d

Stryker price target lowered to $371 from $379 at BTIG

BTIG lowered the firm’s price target on Stryker (SYK) to $371 from $379 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 re...

TipRanks 6d

Stryker price target raised to $370 from $350 at Argus

Argus raised the firm’s price target on Stryker (SYK) to $370 from $350 and keeps a Buy rating on the shares. The firm is confident that the company will be abl...

Analyst ratings

77%

of 30 ratings

Buy

76.7%

Hold

23.3%

Sell

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.